Suppr超能文献

纤溶疗法在髂股静脉新旧血栓形成中的成功率。

The success rate of fibrinolytic therapy in fresh and old thrombosis of the iliac and femoral veins.

作者信息

Theiss W, Wirtzfeld A, Fink U, Maubach P

出版信息

Angiology. 1983 Jan;34(1):61-9. doi: 10.1177/000331978303400108.

Abstract

Since it is still a wide-held belief that fibrinolytic therapy can clear thrombi from deep veins only while they are fresh, we retrospectively analyzed the phlebographic results obtained in 85 patients with thrombosis of the iliac and/or femoral veins with symptoms present for 1 day to 8 weeks prior to treatment. Streptokinase, urokinase, or both drugs successively were administered in these patients for a mean of 9 days (range: 2 to 26 days). Complete or partial resolution of the thrombotic occlusion was obtained in 94%, 82%, and 69%, respectively, in those patients who presented within 3 days, 1 to 2 weeks, and 3 to 4 weeks after the first appearance of symptoms. With a delay of 5 to 8 weeks the results were uniformly poor with only 1 partial recanalization in 7 patients.

摘要

由于人们普遍认为纤溶疗法只能在血栓尚新鲜时清除深静脉血栓,我们回顾性分析了85例髂静脉和/或股静脉血栓形成患者的静脉造影结果,这些患者在治疗前1天至8周出现症状。在这些患者中先后使用链激酶、尿激酶或两种药物,平均用药9天(范围:2至26天)。在症状首次出现后3天内、1至2周以及3至4周就诊的患者中,血栓闭塞完全或部分溶解的比例分别为94%、82%和69%。延迟5至8周就诊时,结果均很差,7例患者中仅有1例部分再通。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验